Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 4, 2023

Quagen Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?

QUAGEN has eighteen approved drugs.

Summary for Quagen

US Patents:	0
Tradenames:	13
Ingredients:	13
NDAs:	18

Drugs and US Patents for Quagen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Quagen	CLOBETASOL PROPIONATE	clobetasol propionate	SOLUTION;TOPICAL	211240-001	Feb 17, 2022	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Quagen	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OIL;TOPICAL	212761-001	Apr 2, 2021	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Quagen	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OIL/DROPS;OTIC	212762-001	Apr 2, 2021	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Quagen	PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE	codeine phosphate; promethazine hydrochloride	SYRUP;ORAL	214238-001	Oct 8, 2020	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Quagen	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	SOLUTION;ORAL	213761-001	Jun 2, 2021	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Quagen	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	PASTE;DENTAL	214582-001	Dec 9, 2022	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Quagen

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Merck

Colorcon

Boehringer Ingelheim

Baxter

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.